Oxford, UK – PrecisionLife CEO Dr Steve Gardner will speak on the panel of today’s ‘Digital Biomarkers – a new dawn in CNS R&D’ to discuss how a stratified medicine approach using proprietary digital biomarkers optimised using AI/ML techniques could discover and validate new targets, as well as significantly reduce the risk of late-stage failure.
For more information please see www.bio.org/events/bio-digital/sessions/619255.